Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol
Status:
Unknown status
Trial end date:
2020-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if imiquimod can be used as a non-invasive option
in the treatment of residual/recurrent CIN lesions.
Phase:
Phase 3
Details
Lead Sponsor:
Erasmus Medical Center
Collaborators:
Albert Schweitzer Hospital Catharina Ziekenhuis Eindhoven Maastricht University Medical Center Meander Medisch Centrum meander medisch centrum Amersfoort Sint Franciscus Gasthuis